[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2004256557A - Antimicrobial agent containing chitosan oligosaccharide and method for suppressing growth of cariogenic bacterium - Google Patents

Antimicrobial agent containing chitosan oligosaccharide and method for suppressing growth of cariogenic bacterium Download PDF

Info

Publication number
JP2004256557A
JP2004256557A JP2004169914A JP2004169914A JP2004256557A JP 2004256557 A JP2004256557 A JP 2004256557A JP 2004169914 A JP2004169914 A JP 2004169914A JP 2004169914 A JP2004169914 A JP 2004169914A JP 2004256557 A JP2004256557 A JP 2004256557A
Authority
JP
Japan
Prior art keywords
chitosan
chitosan oligosaccharide
degree
antibacterial agent
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004169914A
Other languages
Japanese (ja)
Other versions
JP3728513B2 (en
Inventor
Yoshihiko Hayashi
善彦 林
Mamoru Fujiwara
守 藤原
Naoko Ohara
直子 大原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagasaki University NUC
Original Assignee
Nagasaki University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagasaki University NUC filed Critical Nagasaki University NUC
Priority to JP2004169914A priority Critical patent/JP3728513B2/en
Publication of JP2004256557A publication Critical patent/JP2004256557A/en
Application granted granted Critical
Publication of JP3728513B2 publication Critical patent/JP3728513B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a highly effective antimicrobial agent containing a chitosan oligosaccharide and causing no decalcification to dentin, to provide a method for suppressing the growth of cariogenetic bacteria. <P>SOLUTION: The agent contains the chitosan oligosaccharide as an active ingredient. The oligomer of the oligosaccharide preferably has 2-8 polymerization degree and 80-100 degree of deacetylation. More preferably, the agent has pH6.5 or more and the concentration of the oligomer is ≥0.5 wt.%. <P>COPYRIGHT: (C)2004,JPO&NCIPI

Description

本発明は、キトサンオリゴ糖を有効成分として含有したキトサンオリゴ糖含有抗菌薬、および齲蝕原性細菌の発育を抑制する方法に関し、特に、歯科医療の臨床応用としてのみならず、家庭における齲蝕に対する自己ケアにおいても利用できるキトサンオリゴ糖含有抗菌薬および齲蝕原性細菌の発育を抑制する方法に関する。   The present invention relates to a chitosan oligosaccharide-containing antibacterial agent containing chitosan oligosaccharide as an active ingredient, and a method for suppressing the development of cariogenic bacteria, and more particularly to self-care against dental caries at home as well as clinical application of dentistry. The present invention relates to a chitosan oligosaccharide-containing antibacterial agent that can also be used in care and a method for suppressing the growth of cariogenic bacteria.

齲蝕、いわゆる虫歯の予防・抑制に関しては、現在および過去においても、フッ素製剤が世界的にも一般的であるが、近年、キトサンの抗菌作用を利用した歯科医療への応用が注目されている。
キトサンは、カニやエビの外殻に含まれる成分であるキチンを化学処理して得られ、その構造はD−グルコサミンがβ−1,4結合で繋がった形態をしており、種々の脱アセチル化度を有する多糖類である。キトサンは、その生体に対する高い親和性を利用して、人工皮膚としても利用される一方で、近年、齲蝕の一因をなすストレプトコッカスミュータンス菌に対する抗菌作用が報告され(例えば、非特許文献1参照。)、また、キトサンを含有した歯磨剤も報告されている(例えば、特許文献1参照。)。
With regard to the prevention and control of caries, so-called caries, fluorine preparations are generally used worldwide in the present and the past, but in recent years, their application to dentistry using the antibacterial action of chitosan has attracted attention.
Chitosan is obtained by chemical treatment of chitin, which is a component contained in the outer shell of crabs and shrimps, and its structure is a form in which D-glucosamine is linked by β-1,4 bonds. It is a polysaccharide having a degree of conversion. While chitosan is used as artificial skin by utilizing its high affinity for living organisms, in recent years, antibacterial action against Streptococcus mutans that contributes to caries has been reported (for example, see Non-patent Document 1). In addition, a dentifrice containing chitosan has also been reported (see, for example, Patent Document 1).

Kimら著「Carbohydrate Research」2001年、44巻、p.71〜76Kim et al., “Carbohydrate Research” 2001, 44, p. 71-76 特開平9−249541号公報(請求項1)JP-A-9-249541 (Claim 1)

しかし、前者はpH6において齲蝕抑制能を試験しており、このpH値では歯質の脱灰が生じるため、齲蝕予防・抑制のためには、かえって逆効果となる。一方、後者はキトサンを重合度の高いポリマーにおいてのみ試験しており、重合度の低いキトサンの有効性は不明である。
そこで、本発明は、キトサンを有効成分とし、歯質の脱灰が生じないpH値において高い効果を発揮するキトサンオリゴ糖含有抗菌薬を開発することを目的とする。
However, the former is testing the ability to suppress dental caries at pH 6, and at this pH value, demineralization of the tooth occurs, which is rather counterproductive for caries prevention / suppression. On the other hand, the latter has tested chitosan only in polymers with a high degree of polymerization, and the effectiveness of chitosan with a low degree of polymerization is unclear.
Therefore, an object of the present invention is to develop a chitosan oligosaccharide-containing antibacterial agent that has chitosan as an active ingredient and exhibits a high effect at a pH value at which tooth decalcification does not occur.

上記目的を達成するため、本発明者らは、キトサンの抗菌作用に着目し、鋭意研究を行った結果、本発明を完成するに至った。
本発明のキトサンオリゴ糖含有抗菌薬の構成は、キトサンオリゴ糖を有効成分とする。さらに、キトサンオリゴ糖の重合度が2〜8、脱アセチル化度が80〜100%、および/または濃度が0.5重量%以上であると好ましく、キトサンオリゴ糖含有抗菌薬のpH値が6.5以上であるとさらに好ましい。
In order to achieve the above object, the present inventors have paid attention to the antibacterial action of chitosan and conducted intensive studies, thereby completing the present invention.
The chitosan oligosaccharide-containing antibacterial agent of the present invention comprises chitosan oligosaccharide as an active ingredient. Furthermore, it is preferable that the degree of polymerization of chitosan oligosaccharide is 2 to 8, the degree of deacetylation is 80 to 100%, and / or the concentration is 0.5% by weight or more, and the pH value of the chitosan oligosaccharide-containing antibacterial agent is 6 More preferably, it is 5 or more.

本発明のキトサンオリゴ糖含有抗菌薬は、キトサンオリゴ糖を含有しているので、齲蝕細菌発育抑制効果が高く、したがって、歯質を侵す乳酸の生成を効果的に抑制することができ、優れた齲蝕原性細菌の抗菌効果が得られる。
また、pH値を象牙質が脱灰しないpH6.5以上にすることにより、歯肉が退縮して根面が露出したり、エナメル質が傷ついて象牙質に達する微小な隙間がある場合にも、有効に本発明のキトサンオリゴ糖含有抗菌薬を使用することができる。
Since the chitosan oligosaccharide-containing antibacterial drug of the present invention contains chitosan oligosaccharide, it has a high caries bacterial growth inhibitory effect, and therefore can effectively suppress the production of lactic acid that invade the tooth structure, and is excellent. Antibacterial effect of cariogenic bacteria is obtained.
In addition, by setting the pH value to 6.5 or more at which the dentin does not demineralize, the gingiva is retracted and the root surface is exposed, or the enamel is damaged and there is a minute gap reaching the dentin, The chitosan oligosaccharide-containing antibacterial agent of the present invention can be used effectively.

本発明をより詳細に説明する。
キトサンオリゴ糖含有抗菌薬の有効成分をオリゴマーとした理由は、キトサンに関して、その重合度の影響を調べるため、モノマー、オリゴマー、ポリマーについて試験したところ、モノマー、ポリマーに比べ、オリゴマーにおいて有意にミュータンス連鎖球菌に対する発育抑制効果が見られたからである。
本発明では、オリゴ糖の重合度は2〜8の重合度とし、この範囲が好ましい。なお、使用に際してこれら以外の重合度のものを排除する趣旨ではなく、脱アセチル化度80%以上のキトサンオリゴマーが上記所定範囲の重合度を有していればよい。重合度を限定した理由は、これより重合度が高くなると抗菌作用が不十分となるからである。
The present invention will be described in more detail.
The reason why the active ingredient of the chitosan oligosaccharide-containing antibacterial agent is an oligomer is that, in order to investigate the influence of the degree of polymerization of chitosan, the monomer, oligomer, and polymer were tested. It is because the growth inhibitory effect with respect to Streptococcus was seen.
In the present invention, the degree of polymerization of the oligosaccharide is 2 to 8, and this range is preferred. The chitosan oligomer having a degree of deacetylation of 80% or more only needs to have a degree of polymerization in the above-mentioned range. The reason for limiting the degree of polymerization is that if the degree of polymerization is higher than this, the antibacterial action becomes insufficient.

また、キトサンオリゴ糖の脱アセチル化度は80〜100%が好ましい。これは、脱アセチル化度80%未満では抗菌作用が不十分であり、不都合だからである。
さらに、キトサンオリゴ糖含有抗菌薬のpH範囲が6.5以上であることが好ましいのは、象牙質の脱灰を回避するためである。歯質のうち、表面を覆うエナメル質は、象牙質に比べて、耐酸性が強く、脱灰し難い性質を有するが、歯肉が退出して象牙質が露出した根面や、傷ついたエナメル質の微小な隙間が象牙質まで到達している場合に、特に齲蝕予防・抑制の効果が求められ、このような状況においては、キトサンオリゴ糖含有抗菌薬は、象牙質の脱灰を生じないpH値に設定することが望ましいためである。
The degree of deacetylation of chitosan oligosaccharide is preferably 80 to 100%. This is because if the degree of deacetylation is less than 80%, the antibacterial action is insufficient and inconvenient.
Furthermore, the pH range of the chitosan oligosaccharide-containing antibacterial agent is preferably 6.5 or more in order to avoid dentin decalcification. Of the dentine, the enamel that covers the surface is stronger in acid resistance and harder to demineralize than the dentin, but the root surface where the dentin is exposed due to the withdrawal of the gingiva and the damaged enamel When the minute gaps reach the dentin, the effect of caries prevention / suppression is particularly required. In such a situation, the chitosan oligosaccharide-containing antibacterial agent has a pH that does not cause demineralization of the dentin. This is because it is desirable to set the value.

本発明のキトサンオリゴ糖含有抗菌薬中、有効成分であるキトサンオリゴ糖の濃度は0.5重量%以上であることが好ましいが、これは0.5重量%未満では齲蝕予防・抑制効果が低いからである。また、キトサンオリゴ糖の濃度の上限値については、特に制限はないが、濃度が5重量%以上になると、粘度の上昇が激しくて、完全溶解が難くなり、使用上不都合である。   In the chitosan oligosaccharide-containing antibacterial agent of the present invention, the concentration of chitosan oligosaccharide as an active ingredient is preferably 0.5% by weight or more, but if it is less than 0.5% by weight, the caries prevention / suppression effect is low. Because. Further, the upper limit of the concentration of chitosan oligosaccharide is not particularly limited, but when the concentration is 5% by weight or more, the viscosity is remarkably increased and complete dissolution becomes difficult, which is inconvenient in use.

本発明のキトサンオリゴ糖含有抗菌薬は液状、ペースト状、錠剤等であり、塗布剤の形態で使用すると効果的であるが、液状の場合は、洗口液として利用してもよい。特に、齲蝕は口腔内の常在菌によって発症するので、一般的な細菌感染症への対応である殺菌・消毒という方法によらず、うがいにより使用できることが簡便である。
しかし、より効果が高いのは、咬合面の小窩裂溝部、隣接面、歯肉が退出して露出した根面、歯頸部または隣接面に、ペースト状の本剤を直接塗布することである。この場合、塗布後は、少なくとも15分間は、自然乾燥させる等して、唾液との接触を控えることが望ましい。これは、齲蝕細菌発育抑制効果を得るのに必要な濃度を保持するためである。塗布操作には、綿棒、綿花、歯科用具等を使用でき、また家庭では楊枝等を使用してもよい。
なお、上記洗口剤は、超高齢化社会になったわが国において増加傾向にある根面齲蝕の予防・抑制を簡便に行えるため、利用性が高い。
さらに、キトサンは免疫賦活効果も有するため、塗布後、またはうがい後に、そのまま飲み込んだ場合でも支障ないばかりか、健康増進の面からむしろ有益であり、原料も、豊富に存在するカニやエビの外殻を原料とするため、コスト的にも有利であり、汎用性が望める。
The chitosan oligosaccharide-containing antibacterial agent of the present invention is liquid, pasty, tablet, etc., and is effective when used in the form of a coating agent, but in the case of liquid, it may be used as a mouthwash. In particular, since caries develops due to resident bacteria in the oral cavity, it can be easily used by gargle regardless of the method of sterilization / disinfection that is a response to general bacterial infections.
However, it is more effective to apply this paste directly to the pits and fissures of the occlusal surface, the adjacent surface, the root surface exposed from the exit of the gingiva, the cervical region or the adjacent surface. . In this case, it is desirable to refrain from contact with saliva by, for example, natural drying for at least 15 minutes after application. This is to maintain a concentration necessary for obtaining a caries bacterial growth inhibitory effect. For the application operation, a cotton swab, cotton, a dental tool, or the like can be used, and a toothpick or the like may be used at home.
Note that the mouthwash is highly available because it can easily prevent and control root caries that are increasing in Japan, which has become a super-aging society.
Furthermore, chitosan also has an immunostimulatory effect, so it is not only useful for swallowing after application or after gargle, but is also beneficial for health promotion. Since the shell is used as a raw material, it is advantageous in terms of cost, and versatility can be expected.

さらに、ぺースト状にするために、本発明のキトサンオリゴ糖含有抗菌薬に、生体に為害のないグリセロリン酸カルシウム(例えば、ナカライ社製、規格特級品)を例えば5mM以上の濃度で添加すると、カルシウム、リンが歯質に沈着して、歯質の構成成分の補給効果も得られるため好ましい。   Furthermore, in order to make a paste, calcium glycerophosphate that is not harmful to the living body (for example, a standard special product manufactured by Nacalai Co., Ltd.) is added to the chitosan oligosaccharide-containing antibacterial agent of the present invention at a concentration of, for example, 5 mM or more. Phosphorus deposits on the tooth and is preferable because the effect of supplying the constituents of the tooth is obtained.

本発明を具体的に説明する。
(1)重合度およびpH値の影響
下記キトサン(モノマー、オリゴマー、ポリマー)の粉末をそれぞれ0.4%の酢酸水溶液に溶解した後、水酸化ナトリウムを使用して、pH6.0、pH6.5、pH7.4にそれぞれpH調整し、その後、濾過滅菌して、濃度4重量%のキトサン溶液を得る。
コントロールとしては、水酸化ナトリウムで上記各pH値にpH調整した酢酸溶液を使用した。
このようにして得られた各キトサン溶液およびコントロールに、S.mutansを5×10CFU/mlの濃度で加えた後、37℃で1時間反応させ、その後、この反応液0.1mlをトッド−ヘウィット寒天培地に接種し、37℃で48時間培養した。その後、寒天培地上のコロニー数を計測し、下式によりコントロールとの比を算出した。実験は各3回ずつ行い、それぞれの平均値を表1に示す。
比=コロニー数(キトサン溶液)/コロニー数(コントロール)
The present invention will be specifically described.
(1) Effect of degree of polymerization and pH value The following chitosan (monomer, oligomer, polymer) powders were dissolved in 0.4% acetic acid aqueous solution, respectively, and then sodium hydroxide was used to adjust the pH to 6.0, pH 6.5. , PH is adjusted to 7.4, and then sterilized by filtration to obtain a chitosan solution having a concentration of 4% by weight.
As a control, an acetic acid solution adjusted to each pH value with sodium hydroxide was used.
For each chitosan solution and control thus obtained, S. Mutans was added at a concentration of 5 × 10 3 CFU / ml and allowed to react at 37 ° C. for 1 hour. Then, 0.1 ml of this reaction solution was inoculated on Todd-Hewitt agar medium and cultured at 37 ° C. for 48 hours. Thereafter, the number of colonies on the agar medium was counted, and the ratio with the control was calculated by the following formula. Each experiment was performed three times, and the average value of each experiment is shown in Table 1.
Ratio = number of colonies (chitosan solution) / number of colonies (control)

実験に使用した細菌、キトサン(甲陽ケミカル株式会社製)、および培地の詳細は以下の通りである。
齲蝕原性細菌:Streptococcus mutans (GS−5株)
キトサン:
モノマー;コーヨーグルコサミン(キトサンモノマー塩酸塩)
オリゴマー;オリゴグルコサミン(キトサンオリゴマー塩酸塩、2〜8糖の混合物、脱アセチル化度100%)
ポリマー;SK−2(キトサン乳酸塩、分子量約10000、脱アセチル化度80%以上)
培地:トッド−ヘヴッド(Todd−Hewitt)培地
Details of the bacteria, chitosan (manufactured by Koyo Chemical Co., Ltd.), and the medium used in the experiment are as follows.
Cariesogenic bacteria: Streptococcus mutans (GS-5 strain)
Chitosan:
Monomer: Koyoglucosamine (chitosan monomer hydrochloride)
Oligomer: Oligoglucosamine (chitosan oligomer hydrochloride, mixture of 2-8 sugars, degree of deacetylation 100%)
Polymer: SK-2 (chitosan lactate, molecular weight about 10,000, deacetylation degree 80% or more)
Medium: Todd-Hewitt medium

Figure 2004256557

(注)
*印はコントロールに対して危険率1%で有意差が認められることを示す。
平均値約0.2以下を効果ありと判定した。平均値が0.2であるということは、80%の細菌発育抑制効果が得られたことを示す。
Figure 2004256557

(note)
An asterisk (*) indicates that a significant difference is observed at a risk rate of 1% relative to the control.
An average value of about 0.2 or less was determined to be effective. An average value of 0.2 indicates that 80% bacterial growth inhibitory effect was obtained.

表1およびこれをグラフ化した図1に示すように、pH7.4では、モノマー、オリゴマー、ポリマーともコントロールに対比して有効性は見られないが、pH6.5およびpH6.0では、共に、オリゴマーの場合に有効であることがわかる。   As shown in Table 1 and FIG. 1 where this is graphed, at pH 7.4, no monomer, oligomer, or polymer is effective compared to the control, but at pH 6.5 and pH 6.0, It turns out that it is effective in the case of an oligomer.

(2)重合度の影響
上記の方法に準じて、pH値を6.5に設定し、キトサンオリゴマーを使用して、各濃度のキトサン溶液を調製し、上記と同様にコロニー数を計測し、比を算出した。
(2) Influence of degree of polymerization According to the above method, the pH value was set to 6.5, chitosan oligomer was used to prepare chitosan solutions of each concentration, and the number of colonies was measured in the same manner as described above. The ratio was calculated.

Figure 2004256557
Figure 2004256557

表2およびこれをグラフ化した図2からわかるように、0.5重量%以上の濃度において、75%以上の齲蝕細菌発育抑制効果を示している。特に、2重量%の濃度において、最も高い細菌発育抑制効果を示している(齲蝕細菌最少発育阻止濃度)。   As can be seen from Table 2 and FIG. 2 which is a graph of this, 75% or more caries bacterial growth inhibitory effect is shown at a concentration of 0.5% by weight or more. In particular, at the concentration of 2% by weight, the highest bacterial growth inhibitory effect is shown (minimum growth inhibitory concentration of carious bacteria).

なお、上記と同様にして、pH6.5にて、モノマーおよびポリマーについても濃度の影響を調べ、図3および図4にそれぞれ結果を示す。いずれの場合も、コントロールに対比してあまり差がないことがわかる。   In the same manner as described above, the influence of the concentration of the monomer and polymer was examined at pH 6.5, and the results are shown in FIGS. 3 and 4, respectively. In either case, it can be seen that there is not much difference compared to the control.

細菌発育抑制効果に対する、キトサンの重合度とキトサンオリゴ糖含有抗菌薬のpHの影響を示すグラフである。It is a graph which shows the influence of the polymerization degree of chitosan and pH of chitosan oligosaccharide containing antibacterial agent with respect to a bacterial growth inhibitory effect. 細菌発育抑制効果に対する、キトサンオリゴマーの濃度の影響を示すグラフである。It is a graph which shows the influence of the density | concentration of a chitosan oligomer with respect to a bacterial growth inhibitory effect. 細菌発育抑制効果に対する、キトサンモノマーの濃度の影響を示すグラフである。It is a graph which shows the influence of the density | concentration of a chitosan monomer with respect to a bacterial growth inhibitory effect. 細菌発育抑制効果に対する、キトサンポリマーの濃度の影響を示すグラフである。It is a graph which shows the influence of the density | concentration of a chitosan polymer with respect to a bacterial growth inhibitory effect.

Claims (6)

脱アセチル化度が80〜100%であり、かつ重合度が2〜8であるキトサンオリゴ糖を有効成分とし、pH値が6.5以上であって、齲蝕原性細菌の発育抑制作用を有する、キトサンオリゴ糖含有抗菌薬。 A chitosan oligosaccharide having a degree of deacetylation of 80 to 100% and a degree of polymerization of 2 to 8 is used as an active ingredient, has a pH value of 6.5 or more, and has an inhibitory effect on the growth of cariogenic bacteria. Antibiotics containing chitosan oligosaccharides. 前記キトサンオリゴ糖の濃度が0.5重量%以上である請求項1記載の抗菌薬。 The antibacterial agent according to claim 1, wherein the concentration of the chitosan oligosaccharide is 0.5% by weight or more. グリセロリン酸カルシウムをさらに含む請求項1記載の抗菌薬。 The antibacterial agent according to claim 1, further comprising calcium glycerophosphate. 前記齲蝕原性細菌がミュータンス菌である請求項1記載の抗菌薬。 The antibacterial agent according to claim 1, wherein the cariogenic bacterium is a mutans bacterium. 請求項1記載の抗菌薬を塗布することにより齲蝕原性細菌の発育を抑制する方法。 A method for inhibiting the development of cariogenic bacteria by applying the antibacterial agent according to claim 1. 前記齲蝕原性細菌がミュータンス菌である請求項5記載の方法。 6. The method according to claim 5, wherein the cariogenic bacterium is a mutans bacterium.
JP2004169914A 2004-06-08 2004-06-08 Chitosan oligosaccharide-containing antibacterial agent, a method for inhibiting the development of cariogenic bacteria Expired - Lifetime JP3728513B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004169914A JP3728513B2 (en) 2004-06-08 2004-06-08 Chitosan oligosaccharide-containing antibacterial agent, a method for inhibiting the development of cariogenic bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004169914A JP3728513B2 (en) 2004-06-08 2004-06-08 Chitosan oligosaccharide-containing antibacterial agent, a method for inhibiting the development of cariogenic bacteria

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002256443A Division JP2004091413A (en) 2002-09-02 2002-09-02 Agent for preventing and inhibiting dental caries containing chitosan oligosaccharide

Publications (2)

Publication Number Publication Date
JP2004256557A true JP2004256557A (en) 2004-09-16
JP3728513B2 JP3728513B2 (en) 2005-12-21

Family

ID=33128751

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004169914A Expired - Lifetime JP3728513B2 (en) 2004-06-08 2004-06-08 Chitosan oligosaccharide-containing antibacterial agent, a method for inhibiting the development of cariogenic bacteria

Country Status (1)

Country Link
JP (1) JP3728513B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007314505A (en) * 2006-04-28 2007-12-06 Nagasaki Univ Functional chewing gum
CN109662901A (en) * 2017-10-16 2019-04-23 天垚生命科学(深圳)有限公司 A kind of toothpaste and preparation method thereof containing chitobiose

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007314505A (en) * 2006-04-28 2007-12-06 Nagasaki Univ Functional chewing gum
CN109662901A (en) * 2017-10-16 2019-04-23 天垚生命科学(深圳)有限公司 A kind of toothpaste and preparation method thereof containing chitobiose

Also Published As

Publication number Publication date
JP3728513B2 (en) 2005-12-21

Similar Documents

Publication Publication Date Title
US10765616B2 (en) Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
JP6650785B2 (en) Oral care method and composition using chitosan derivative compound
EP3187169B1 (en) Oral composition for alleviation of dentin hypersensitivity
US10470993B2 (en) Tooth remineralization compositions and methods
CN107693392B (en) Toothpaste containing enzyme preparation and preparation method thereof
JP3710135B2 (en) Calculus dissolution agent
WO2007055372A1 (en) Composition for oral use
CN101972215A (en) Chitosan oligosaccharide oral cavity cleaning tablet
JPS6216923B2 (en)
JP5402613B2 (en) Dentifrice composition
JP3728513B2 (en) Chitosan oligosaccharide-containing antibacterial agent, a method for inhibiting the development of cariogenic bacteria
CN107280978A (en) Remineralization of teeth technology based on chitosan-amorphous calcium phosphate
JP2003246717A (en) Composition for oral cavity
JP2004091413A (en) Agent for preventing and inhibiting dental caries containing chitosan oligosaccharide
JP2007126409A (en) Agent for dissolution of dental calculus
JP3022047B2 (en) Oral composition
Chauhan et al. APPLICATIONS OF CHITOSAN IN DENTISTRY-A REVIEW ARTICLE
KR20110062519A (en) Compounds for dental bleaching
KR20080101955A (en) Powder-type dentifrice composition contained gold particles
JP4588348B2 (en) Tartar and caries removal agent
Heryumani et al. Effect of Dentifrice Containing Crab‑Shell Chitosan on the Accumulation of Dental Plaque in Fixed Orthodontic Appliances Patients: A Randomized Controlled Trial
JP2005139201A (en) Agent for dissolving dental calculi and dental caries
JPH0517325A (en) Medicine for dental caries
CN118576531A (en) Metazoan composition toothpaste and preparation method thereof
JP2005320301A (en) Root canal cleaning liquid

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040608

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20040903

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20050315

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20050406

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050617

TRDD Decision of grant or rejection written
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050728

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050906

R150 Certificate of patent or registration of utility model

Ref document number: 3728513

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

EXPY Cancellation because of completion of term